Netherlands· NL-7e726088c2db
Bimatoprost SDZ 0,1 mg/ml oogdruppels, oplossing
A bimatoprost product containing bimatoprost, registered in Netherlands by Sandoz B.V.. The same ATC class is registered in 19 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Bimatoprost is registered in 19 of 19 countries.
Countries holding a registration under ATC S01EE03 (bimatoprost), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 11 of them publish a price we can compare per daily dose
Bimatoprost · ATC S01EE03
19 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- BIMATOPROST
- Manufacturer
- Sandoz B.V.
- Country
- Netherlands (NL)
- ATC code
- S01EE03
- ATC class
- Bimatoprost
- Defined daily dose
- 0.1 ml, AT
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_id128173
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
89 interactions on record for bimatoprost.
Graded by severity as the source publishes them — 89 info. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Bimatoprost · interactions on record
89 records
Same medicine, other countries
Bimatoprost in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesBimatoprostLifestar Pharma LLC
- FranceBIMATOPROST BIOGARAN 0,1 mg/mL, collyre en solutionBIOGARAN
- BelgiumBimatoprost EG 0.1 mg/mlEG
- FinlandBimatoprost AccordAccord Healthcare B.V.
- NorwayBimaprezBlumont Ofta Trading Limited
- SwedenBimaprez 0,1 mg/ml Ögondroppar, lösningBlumont Ofta Trading Ltd
- CzechiaLUMIGANAbbVie Deutschland GmbH & Co.KG, Ludwigshafen
- SwitzerlandLumigan, 0.1 mg/ml, AugentropfenAbbVie AG
Authorised across Europe · EMA
The same active substance is authorised in 28 EEA countries. Names it is sold under:
- Austria · Bima-Vision Sine, Bimato-Vision
- Belgium · Bimatoprost Eg, Bimatoprost Eg (Eurogenerics)
- Bulgaria · Бимаган, Биматопрост Абр
- Cyprus · Bimatoprost Pharmathen, Birmost
- Czechia · Bimatoprost Farmaprojects, Bimatoprost Olikla
- Germany · Amiriox, Bimato-Vision
- Denmark · Bimatoprost "hexal", Bimatoprost "stada"
- Estonia · Elymbus
- Spain · Amiriox, Bamixol
- Finland · Bimatoprost, Bimatoprost Sandoz
- France · Amiriox, Bimatoprost
- United Kingdom (Northern Ireland) · Amiriox, Bimatoprost Alissa Healthcare Research
- Greece · Birmost, Dacrysan
- Croatia · Elymbus
- Ireland · Elymbus, Eyreida
- Iceland · Bimatoprost, Elymbus
- Italy · Amiriox, Bialviz
- Liechtenstein · Lumigan
- Lithuania · Bimican, Bimifree
- Luxembourg · Bimatoprost Eg, Bimatoprost Eg (Eurogenerics) Nv
- Latvia · Bimican, Bimifre
- Norway · Bimaprez, Bimatoprost Hexal
- Poland · Bimican, Bimifree
- Portugal · Amiriox, Bimatoprost Stulln
- Romania · Amiriox, Bimagan
- Sweden · Bimaprez, Bimatoprost
- Slovenia · Elymbus
- Slovakia · Bimatoprost Olikla, Elymbus
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/eea3d167-da47-4fdd-9e4c-ce8e57e8021e GET /v1/drugs/eea3d167-da47-4fdd-9e4c-ce8e57e8021e?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Oogdruppels, oplossing",
"route": "Oculair gebruik",
"soort": "RVG",
"source": "cbg_meb",
"smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h128173_smpc.pdf",
"strength": null,
"atc_label": "Bimatoprost",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg128173",
"excipients": [
"BENZALKONIUMCHLORIDE",
"CITROENZUUR 1-WATER (E 330)",
"DINATRIUMWATERSTOFFOSFAAT 7-WATER (E 339)",
"NATRIUMCHLORIDE",
"NATRIUMHYDROXIDE (E 524)",
"WATER VOOR INJECTIE",
"ZOUTZUUR (E 507)"
],
"substances": [
"BIMATOPROST"
],
"leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h128173.pdf",
"authorised_at": "2022/10/06",
"procedure_number": "AT/H/1207/002",
"dispensing_status": "Uitsluitend recept",
"registration_number": "128173",
"additional_monitoring": "N"
}See everything about bimatoprost.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.